High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy - PubMed (original) (raw)

Case Reports

. 1998 Dec 3;12(17):2358-9.

• PMID: 9863885

Case Reports

High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy

V Jubault et al. AIDS. 1998.

No abstract available

PubMed Disclaimer

Similar articles

• Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy.
  Galli M, Balotta C, Meroni L, Colombo MC, Papagno L, Bagnarelli P, Testa L, Varchetta S, Colombo L, Moroni M, d'Arminio Monforte A, Clerici M, Clementi M. Galli M, et al. AIDS. 1998 Dec 24;12(18):2500-2. AIDS. 1998. PMID: 9875591 No abstract available.
• Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
  Clark NM, Dieng Sarr A, Sankalé JL, Kanki PJ, Kazanjian P, Winfield R, Markovitz DM. Clark NM, et al. AIDS. 1998 Dec 24;12(18):2506-7. AIDS. 1998. PMID: 9875594 No abstract available.
• Antiretroviral therapy in human immunodeficiency virus-infected individuals.
  Spooner KM. Spooner KM. Adv Intern Med. 1998;43:373-402. Adv Intern Med. 1998. PMID: 9506188 Review. No abstract available.
• Antiretroviral therapy: where are we?
  Hammer SM, Yeni P. Hammer SM, et al. AIDS. 1998;12 Suppl A:S181-8. AIDS. 1998. PMID: 9633001 Review. No abstract available.

Cited by

• Sequence Analysis of Inducible, Replication-Competent Virus Reveals No Evidence of HIV-1 Evolution During Suppressive Antiviral Therapy, Indicating a Lack of Ongoing Viral Replication.
  Lee SK, Sondgeroth A, Xu Y, Warren J, Zhou S, Gilleece M, Hauser BM, Gay CL, Kuruc JD, Archin NM, Eron JJ, Margolis DM, Goonetilleke N, Swanstrom R. Lee SK, et al. Open Forum Infect Dis. 2024 Apr 17;11(5):ofae212. doi: 10.1093/ofid/ofae212. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38756763 Free PMC article.
• The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.
  Joseph SB, Abrahams MR, Moeser M, Tyers L, Archin NM, Council OD, Sondgeroth A, Spielvogel E, Emery A, Zhou S, Doolabh D, Ismail SD, Karim SA, Margolis DM, Pond SK, Garrett N, Swanstrom R, Williamson C. Joseph SB, et al. PLoS Pathog. 2024 Feb 29;20(2):e1011974. doi: 10.1371/journal.ppat.1011974. eCollection 2024 Feb. PLoS Pathog. 2024. PMID: 38422171 Free PMC article.
• Can HIV Be Cured and Should We Try?
  Cummins NW, Badley AD. Cummins NW, et al. Mayo Clin Proc. 2015 Jun;90(6):705-9. doi: 10.1016/j.mayocp.2015.03.008. Epub 2015 May 2. Mayo Clin Proc. 2015. PMID: 25944260 Free PMC article. No abstract available.
• A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients.
  Yu JJ, Wu TL, Liszewski MK, Dai J, Swiggard WJ, Baytop C, Frank I, Levine BL, Yang W, Theodosopoulos T, O'Doherty U. Yu JJ, et al. Virology. 2008 Sep 15;379(1):78-86. doi: 10.1016/j.virol.2008.05.030. Epub 2008 Jul 22. Virology. 2008. PMID: 18649912 Free PMC article.
• Immunotherapy with canarypox vaccine and interleukin-2 for HIV-1 infection: termination of a randomized trial.
  Smith KA, Andjelic S, Popmihajlov Z, Kelly-Rossini L, Sass A, Lesser M, Benkert S, Waters C, Ruitenberg J, Bellman P. Smith KA, et al. PLoS Clin Trials. 2007 Jan 26;2(1):e5. doi: 10.1371/journal.pctr.0020005. PLoS Clin Trials. 2007. PMID: 17260026 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wolters Kluwer

• Medical

  • MedlinePlus Health Information